These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28490930)

  • 41. Use of metformin is associated with lower incidence of cancer in patients with type 2 diabetes.
    Muszyńska-Ogłaza A; Zarzycka-Lindner G; Olejniczak H; Polaszewska-Muszyńska M; Junik R
    Endokrynol Pol; 2017; 68(6):652-658. PubMed ID: 29022647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of prolonged exposure to low dose metformin in thyroid cancer cell lines.
    Kheder S; Sisley K; Hadad S; Balasubramanian SP
    J Cancer; 2017; 8(6):1053-1061. PubMed ID: 28529619
    [No Abstract]   [Full Text] [Related]  

  • 43. A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy.
    Pimentel I; Lohmann AE; Ennis M; Dowling RJO; Cescon D; Elser C; Potvin KR; Haq R; Hamm C; Chang MC; Stambolic V; Goodwin PJ
    Breast; 2019 Dec; 48():17-23. PubMed ID: 31472446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metformin and Breast Cancer: Molecular Targets.
    Faria J; Negalha G; Azevedo A; Martel F
    J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial.
    Nanni O; Amadori D; De Censi A; Rocca A; Freschi A; Bologna A; Gianni L; Rosetti F; Amaducci L; Cavanna L; Foca F; Sarti S; Serra P; Valmorri L; Bruzzi P; Corradengo D; Gennari A;
    Breast Cancer Res Treat; 2019 Apr; 174(2):433-442. PubMed ID: 30536182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metformin and other anti-diabetic medication use and breast cancer incidence in the Nurses' Health Studies.
    Wang T; Chai B; Chen WY; Holmes MD; Erdrich J; Hu FB; Rosner BA; Tamimi RM; Willett WC; Kang JH; Eliassen AH
    Int J Cancer; 2024 Jul; 155(2):211-225. PubMed ID: 38520039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exploring the Relationship Between Diabetes and Breast Cancer in the United Arab Emirates.
    Alharmoodi F; Al Ameri MA; Alblooshi M; Shanbhag NM; Almheiri MH; Bin Sumaida A
    Cureus; 2024 Feb; 16(2):e54787. PubMed ID: 38405646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AMPK phosphorylates and stabilises copper transporter 1 to synergise metformin and copper chelator for breast cancer therapy.
    Zhang X; Jiang Q; Su Y; Bu L; Sun Z; Wu X; Gao B; Wang L; Lin Y; Xie W; Guo J
    Br J Cancer; 2023 Apr; 128(8):1452-1465. PubMed ID: 36807336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks.
    Sorrenti V; Benedetti F; Buriani A; Fortinguerra S; Caudullo G; Davinelli S; Zella D; Scapagnini G
    Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 35893737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metformin and Breast Cancer: Where Are We Now?
    Cejuela M; Martin-Castillo B; Menendez JA; Pernas S
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer.
    Park YM; Bookwalter DB; O'Brien KM; Jackson CL; Weinberg CR; Sandler DP
    Ann Oncol; 2021 Mar; 32(3):351-359. PubMed ID: 33516778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resveratrol, Rapamycin and Metformin as Modulators of Antiviral Pathways.
    Benedetti F; Sorrenti V; Buriani A; Fortinguerra S; Scapagnini G; Zella D
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33348714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer.
    Samuel SM; Varghese E; Kubatka P; Triggle CR; Büsselberg D
    Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31835318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metformin as an adjuvant in breast cancer treatment.
    Roshan MH; Shing YK; Pace NP
    SAGE Open Med; 2019; 7():2050312119865114. PubMed ID: 31360518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metformin and breast cancer stage at diagnosis: a population-based study.
    Lega IC; Fung K; Austin PC; Lipscombe LL
    Curr Oncol; 2017 Apr; 24(2):e85-e91. PubMed ID: 28490930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The association between diabetes and breast cancer stage at diagnosis: a population-based study.
    Lipscombe LL; Fischer HD; Austin PC; Fu L; Jaakkimainen RL; Ginsburg O; Rochon PA; Narod S; Paszat L
    Breast Cancer Res Treat; 2015 Apr; 150(3):613-20. PubMed ID: 25779100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A population-based study of ethnicity and breast cancer stage at diagnosis in Ontario.
    Ginsburg OM; Fischer HD; Shah BR; Lipscombe L; Fu L; Anderson GM; Rochon PA
    Curr Oncol; 2015 Apr; 22(2):97-104. PubMed ID: 25908908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between Metformin Use and Mortality after Cervical Cancer in Older Women with Diabetes.
    Han K; Pintilie M; Lipscombe LL; Lega IC; Milosevic MF; Fyles AW
    Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):507-12. PubMed ID: 26721670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
    Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
    Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.